Is Novavax Stock A Buy Or A Sell As Shares Stage A Comeback On A Cost-Cutting Plan?
offered an upbeat sales outlook and announced a cost-cutting plan in mid-May, but NVAX stock has since slipped back below its 50-day line. X First-quarter sales lagged forecasts, but the company says it's on track to deliver an updated Covid vaccine this fall, alongside rivals Pfizer (PFE) and…
#nvax #pfe #pfizer #moderna #rna #novavax #tdcowen #brendansmith #losses #covidvaccine